Evoke Pharma Earlier Reported Q3 EPS $(0.07) Up From $(0.09) YoY

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year.

Benzinga · 11/07/2019 14:52

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year.